LAMP2 and ovarian carcinoma: First, we detected co-localization of ferritin and lysosome labels, and the results show that the co-localization of NCOA4 and lysosome (LAMP2) was significantly inhibited in C-MYC-over-expressed ovarian cancer cells, while NCOA4 up-regulation could reverse this change (Figure 2A,C).